Uracil

apolipoprotein B mRNA editing enzyme catalytic subunit 3B ; Homo sapiens







14 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34998823 m6A demethylation of cytidine deaminase APOBEC3B mRNA orchestrates arsenic-induced mutagenesis. 2022 Feb 1
2 33592502 APOBEC3B is preferentially expressed at the G2/M phase of cell cycle. 2021 Mar 26 2
3 31165764 Protein kinase A inhibits tumor mutator APOBEC3B through phosphorylation. 2019 Jun 5 2
4 31611371 The deaminase APOBEC3B triggers the death of cells lacking uracil DNA glycosylase. 2019 Oct 29 2
5 28535155 Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells. 2017 Jun 27 1
6 28952713 Observation by Real-Time NMR and Interpretation of Length- and Location-Dependent Deamination Activity of APOBEC3B. 2017 Nov 17 2
7 28981865 Enzyme cycling contributes to efficient induction of genome mutagenesis by the cytidine deaminase APOBEC3B. 2017 Nov 16 1
8 25566802 APOBEC3B: pathological consequences of an innate immune DNA mutator. 2015 Mar-Apr 1
9 26051357 High APOBEC3B expression is a predictor of recurrence in patients with low-risk clear cell renal cell carcinoma. 2015 Aug 1
10 26281709 Characterization of the Catalytic Domain of Human APOBEC3B and the Critical Structural Role for a Conserved Methionine. 2015 Sep 25 1
11 26544511 Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif. 2015 Nov 24 1
12 23389445 APOBEC3B is an enzymatic source of mutation in breast cancer. 2013 Feb 21 1
13 23852168 Evidence for APOBEC3B mutagenesis in multiple human cancers. 2013 Sep 1
14 24154874 APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma. 2013 Dec 15 2